PanGenetics B.V.

Vencerx Therapeutics, a company focused on neurodevelopmental disorders, has appointed Robert H. Ring CEO and Jeffrey Stevenson chair of the company’s board of directors. Most recently, Ring wa

Kymab Ltd. CEO Dr David Chiswell OBE has more than 30 years of experience in the biotechnology industry, having co-founded Cambridge Antibody Technology Group PLC in 1990, a company that origina

Crescendo Biologics Ltd. has appointed Kevin Johnson non-executive chair of the board of directors – effective immediately. Johnson has 27 years' experience in antibody development and previously was

Atara Biotherapeutics Inc. , a drug developer spun out of Amgen Inc. last year, has revealed new details about its programs, as well as the $58.5 million it has secured in two rounds of funding f